Detalhe da pesquisa
1.
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.
Blood;
143(16): 1565-1575, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38252906
2.
Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the phase 3 TRANSFORM study.
Blood;
141(14): 1675-1684, 2023 04 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36542826
3.
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.
Blood;
139(3): 413-423, 2022 01 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34570876
4.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
J Natl Compr Canc Netw;
22(3): 175-204, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38626800
5.
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.
Lancet;
399(10343): 2294-2308, 2022 06 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35717989
6.
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes.
Haematologica;
108(11): 3025-3032, 2023 11 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37102592
7.
Cellular therapy in lymphoma.
Hematol Oncol;
2023 Jun 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37382086
8.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood;
136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32688395
9.
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022.
J Natl Compr Canc Netw;
20(6): 622-634, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35714675
10.
Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Lancet;
395(10232): 1278-1291, 2020 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32305093
11.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica;
106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33538152
12.
Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Cancer;
126(1): 189-201, 2020 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31509235
13.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw;
18(2): 185-217, 2020 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32023533
14.
Embracing chimeric antigen receptors for relapsed chronic lymphocytic leukaemia.
Lancet;
402(10402): 590-592, 2023 08 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37597880
15.
A cauldron of choices.
Blood;
139(21): 3103-3104, 2022 05 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35616990
16.
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Blood;
130(2): 221-228, 2017 07 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28468799
17.
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.
J Natl Compr Canc Netw;
17(1): 12-20, 2019 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30659125
18.
Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen.
Future Oncol;
: 1-11, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38547003
19.
Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.
Biol Blood Marrow Transplant;
24(8): 1671-1677, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29684565
20.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood;
138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34297826